A Combination Of Cancer Immunotherapies Could Save More Lives | Latest News RSS feed

A Combination Of Cancer Immunotherapies Could Save More Lives - Latest News


A combination of cancer immunotherapies could save more lives

The pre-clinical study, published in Clinical Cancer Research, by Dr Sarah Buchan and colleagues, combined antibodies targeting PD-1/PD-L1, a type of immunotherapy known as checkpoint blockade that ov... read more

Neoadjuvant combination checkpoint blockade trial yields high response rates for patients with high-risk stage three melanoma

Combination ... save patients' lives. Due to the results of this study, the team re-designed the study to explore the safety and efficacy of nivolumab plus relatlimab, an inhibitor of the LAG3 immune ... read more

Allison’s Nobel Prize beckons new era of immunotherapy

Then the cancer roared back. 1966: Charles Huggins for his work showing that estrogen therapy or androgen ablation could control prostate ... at the tip of the iceberg, but immunotherapy has potential ... read more

Looking for another news?


It May Soon Be Possible to Screen for Ovarian Cancer

For more, visit TIME Health. Ovarian cancer is the fourth-leading cause of cancer deaths ... MORE: Removing Ovaries During Breast Cancer Could Save Lives, New Research Says But scientists report in Th... read more


Widespread screening for breast cancer didn't do much to save women's lives, study finds

More than half of these cancers were harmless ... diagnosed with — and probably treated for — breast cancer. In their other scenario, none of that wasted treatment was offset by saved lives. The resul... read more

BioLineRx/Roche Scan BL-8040-Tecentriq for Pancreatic Cancer

In Sep 2016, BioLineRx had announced initiation of the first phase IIa COMBAT study for evaluating the efficacy of BL-8040 in combination with Merck’s MRK Keytruda in patients with pancreatic cancer . ... read more

Natural killer cells may open lifesaving cancer treatements to more patients

Cancer researchers have just discovered a way to make immunotherapy viable to thousands by using the body's own natural killer (NK) cells in a new way. Immunotherapy is making headlines for saving the ... read more

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

In the absence of toxic effects, nab-paclitaxel was to be administered for six cycles or more. In the absence of disease progression, the discontinuation of atezolizumab or placebo or of nab-paclitaxe... read more

AI is giving the entire medical field super powers

The combination of human and machine has proven to be a successful ... Credit: Art Medical Art Medical founder and CEO, Liron Elia says: With these new algorithms, we hope to save more lives in hospit... read more

The Supply and Demand Side of the Opioid Epidemic

An opioid epidemic is destroying lives across America ... of the drugs without cancer or hospice care diagnoses. And Ohio is just one state in the nation! The ugly truth is that the health care system ... read more

Neoadjuvant combination checkpoint blockade trial yields high response rates for patients with stage 3 melanoma

Patients received either the PD-1 inhibitor nivolumab or the combination of nivolumab and the CTLA-4 checkpoint inhibitor ipilimumab. Each drug blocks a separate off-switch on T cells, freeing the imm... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us